598 J. Agric. Food Chem., Vol. 56, No. 2, 2008
Masuda et al.
Tyrosinase Inhibition Assay. The tyrosinase inhibitory activity was
evaluated by using L-DOPA. The 96-well microplate method previously
reported by Masuda (24) was employed. Briefly, eight wells in total
were designated A (three wells), B (one well), C (three wells), and D
(one well), which contained the following reaction mixtures: A, 120
µL of a 1/15 M phosphate buffer (pH 6.8) and 40 µL of tyrosinase (46
units/mL) in the same buffer; B, 160 µL of the same buffer; C, 80 µL
of the same buffer, 40 µL of tyrosinase (46 units/mL) in the same buffer,
40 µL of an appropriate amount of the sample-buffer solution
containing 5% DMSO to dissolve the sample; D, 120 µL of the same
buffer and 40 µL of the same amount of the sample solution containing
5% DMSO. As a positive control experiment, kojic acid (final
concentration ) 0.03 mM) was used for a reference sample. The
contents of each well were mixed and then incubated at 23 °C for 10
min, before 2.5 mM L-DOPA in the same buffer was added. After
incubation at 23 °C for 2 min, the absorbance at 475 nm of each well
was measured. The percentage inhibition of the tyrosinase activity was
calculated according to the following equation: {[(A - B) - (C - D)]/
(A - B)} × 100. In the experiment for crude samples such as extract
and fraction, the addition orders of tyrosinase and L-DOPA was
inverted, because some phenolics in the extract reacted with tyrosinase
to interfere the oxidation of L-DOPA.
Extraction and Fractionation. The dry leaves of lemongrass (4
kg) were soaked in methanol (36 L) at room temperature for 2 weeks.
After filtration, the filtrate was evaporated under reduced pressure to
give a methanol extract (434 g). The extract (5.1 g) was partitioned
with hexane (50 mL) and methanol/water (9:1, 50 mL) to give a hexane-
soluble fraction and a methanol-soluble fraction. After removal of the
solvent, the methanol-soluble fraction was suspended in water (50 mL)
and sequentially extracted with ethyl acetate (50 mL) and n-butanol
(50 mL) to give an ethyl acetate-soluble fraction and a butanol-soluble
fraction, respectively. After evaporation, the yields of these fractions
were 1.5 g for the hexane extract, 1.3 g for the ethyl acetate extract,
and 0.7 g for the butanol extrtact. The remaining water layer was
evaporated to give the water extract (1.6 g). These extracts were used
for inhibitory assay.
From 200 g of the methanol extract was prepared 54 g of an active
ethyl acetate extract according to the same procedure as described
above. Ten grams of the ethyl acetate extract was loaded on a silica
gel column (600 mL) and eluted stepwise with 2.5% methanol in
chloroform (1.8 L), 5% methanol in chloroform (1.8 L), 10% methanol
in chloroform (1.8 L), 20% methanol in chloroform (1.2 L), and 30%
methanol in chloroform (1.2 L). The eluate was collected in every ca.
70 mL, and the obtained fractions (total of 109 fractions) were combined
to 21 fractions according to the similarity analysis for the constituents
of each fraction using silica gel TLC. The 21 fractions were subjected
to inhibitory assay after evaporation.
Figure 1. Chemical structures of geranic acid and related compounds.
Preparation of Ester Derivatives of Geranic Acid. To a solution
of geranic acid (201 mg, a mixture of trans and cis isomers) in
dichloromethane (7 mL) were added dimethylaminopyridine (73 mg),
dimethylaminopyridine hydrochloride (95 mg), ethanol (0.6 mL), and
dicyclohexylcarbodiimide (495 mg), sequentially. After 1 h of stirring
at 23 °C, acetic acid (0.2 mL) and methanol (0.4 mL) were added to
the mixture. After the addition of diethyl ether (40 mL), the produced
precipitate was filtered off. The filtrate was concentrated and subjected
to silica gel column chromatography eluted with chloroform/hexane
(1:6) to give geranic acid ethyl ester (3, 194 mg, 2:1 mixture of trans
and cis isomers): EI-MS, m/z 196 [M]+; 1H NMR (trans isomer)
(CDCl3) δ 1.28 (3H, t, J ) 7.5 Hz), 1.59 (3H, s), 1.67 (3H, s), 2.01
(7H, br s), 4.14 (2H, q, J ) 7.5 Hz), 5.06 (1H, m), 5.65 (1H, s).
A similar procedure using ethylene glycol instead of ethanol was
employed to synthesize geranic acid ethylene glycol ester (4, 76 mg,
2:1 mixture of trans and cis isomers) from geranic acid (105 mg): EI-
1
MS, m/z 212 [M]+; H NMR (trans isomer) (CDCl3) δ 1.60 (3H, s),
1.68 (3H, s), 2.15 (7H, br s), 3.84 (2H, m), 4.21 (2H, m), 5.07 (1H,
m), 5.71 (1H, s).
Preparation of an Amide Derivative of Geranic Acid. To the
hydroxysuccinimide ester of geranic acid (100 mg), which was prepared
from geranic acid, hydroxysuccinimide, and dicyclohexylcarbodiimide,
was added a chloroform solution (6 mL) of ethylamine hydrochrolide
(154 mg) and triethylamine (0.2 mL). After 20 min of stirring at 23
°C, the mixture was evaporated and subjected to silica gel column
chromatography eluted with ethyl acetate/hexane (1:4) to give geranic
acid ethyl amide (5, 32 mg, 2:1 mixture of trans and cis isomers): EI-
Isolation of Tyrosinase Inhibitory Substance. The most active
fraction 5 (1.1 g) of the above-mentioned silica gel chromatography was
purified again by silica gel column chromatography eluted with ethyl
acetate/hexane (1:4) to give 0.27 g of a fraction containing active substance.
To remove the lipidic impurity, 123 mg of the fraction was purified by
Sephadex LH-20 column chromatography eluted with isopropanol. Finally,
silica gel TLC purification (ethyl acetate/hexane ) 1:5) gave active
compounds 1 (14 mg, Rf ) 0.36) and 2 (5.5 mg, Rf ) 0.54).
1
MS, m/z 195 [M]+; H NMR (trans isomer) (CDCl3) δ 1.14 (3H, t, J
1
1 (trans-geranic acid): EI-MS, m/z 168 [M]+; H NMR (CDCl3) δ
) 7.2 Hz), 1.59 (3H, s), 1.68 (3H, s), 2.03–2.18 (4H, m), 2.12 (3H, s),
3.30 (2H, q, J ) 7.2 Hz), 5.06 (1H, m), 5.33 (1H, br), 5.53 (1H, s).
Preparation of Geranial and Farnesyl Aldehyde. To a solution
of geraniol (6, 306 mg) in hexane (15 mL) was added activated
manganese dioxide (4 g). After 4 h of stirring at room temperature,
the manganese dioxide was filtered off. The obtained filtrate was
evaporated and subjected to silica gel column chromatography eluted
with chloroform/hexane (1:1) to give geranial (7, 222 mg): EI-MS,
m/z 152 [M]+; 1H NMR (CDCl3) δ 1.62 (3H, s), 1.68 (3H, s), 2.17–2.28
(4H, m), 2.17 (3H, s), 5.07 (1H, m), 5.88 (1H, br t, J ) 7.5 Hz), 9.99
(1H, d, J ) 7.5 Hz).
According to a similar procedure, farnesyl aldehyde (14, 281 mg)
was synthesized from farnesol (400 mg): EI-MS, m/z 220 [M]+; 1H
NMR (CDCl3) δ 1.59 (6H, s), 1.67 (3H, s), 1.98 (2H, m), 2.04 (2H,
m), 2.15–2.28 (4H, m), 2.17 (3H, s), 5.08 (2H, m), 5.84 (1H, br d, J )
8.5 Hz), 9.98 (1H, d, J ) 8.5 Hz).
1.59 (3H, s, H-8 or 9), 1.66 (3H, s, H-8 or 9), 2.12 (3H, s, H-10), 2.13
(4H, m, H-4 and 5), 5.04 (1H, br s, H-6), 5.66 (1H, br s, H-2), 12.0
(1H, br, COOH); 13C NMR (CDCl3) δ 17.7 (C-9 or 10), 19.1 (C-9 or
10), 25.7 (C-8), 26.0 (C-5), 41.2 (C-4), 115.1 (C-2), 122.8 (C-6), 132.7
(C-7), 163.1 (C-3), 172.1 (C-1).
2 (cis-geranic acid): EI-MS m/z 168 [M]+; 1H NMR (CDCl3) δ 1.58
(3H, s, H-8 or 9), 1.66 (3H, s, H-8 or 9), 1.91 (3H, s, H-10), 2.14 (2H,
dt, J ) 8.0 and 7.0 Hz, H-5), 2.62 (2H, t, J ) 8.0 Hz, H-4), 5.12 (1H,
br t, J ) 7.0 Hz, H-6), 5.66 (1H, br s, H-2).
Preparation of trans- and cis-Geranic Acids (1 and 2). Com-
mercially available crude geranic acid (a mixture of mainly trans and
cis isomers) was separated by silica gel TLC (5 mg of sample loaded
on a 20 cm × 20 cm plate), which was developed twice with ethyl
acetate/hexane (1:5). From 44 mg of crude geranic acid were obtained
pure trans-geranic acid (1, 21 mg) and cis-geranic acid (2, 20 mg).